Sales Growth YoY (Last 12 Months): Theriva Biologics, Inc. (TOVX)

Theriva Biologics, Inc. (TOVX) adheres to ESG principles by strictly controlling biohazardous waste and research ethics. The sales dynamics over the last 12 months year-over-year demonstrate current trends, where the 0.00 indicator expresses the state of the metric. The financial stability of Theriva Biologics, Inc. (TOVX) depends on grants and test outcomes in the absence of stable revenue, although the company successfully retains its staff of leading oncologists and experts.
Theriva Biologics (TOVX) - metric breakdowns and financial figures

Assessing the financial stability of Theriva Biologics, Inc. (TOVX) requires an analysis of the company's ability to generate revenue against the backdrop of colossal R&D expenditures and stringent FDA oversight. The rolling year-over-year sales growth trajectory measures the percentage change in revenue over the last 12 months relative to the previous period, allowing investors to evaluate the commercial viability of the biotechnologies under high regulatory pressure.